Our Team

Overview

The clinical program consists of pulmonary physicians collaborating closely with thoracic radiology, interventional pulmonology, pulmonary pathology, thoracic surgery, rheumatology, gastroenterology and transplant medicine. The program fosters a multidisciplinary approach to diagnosis and treatment of interstitial lung diseases, and is centered on the weekly multidisciplinary interstitial lung disease conference which is attended regularly by these experts.

Given the relative rarity of the disorder, the diagnosis and the optimal therapeutic approach to a complicated interstitial lung disease can be less than clear even to the most experienced physicians working in isolation. The team members, each an expert in their own field, contribute to the final diagnostic and treatment plan for each of our patients. The patient may see one of many of these specialists during their clinical visits. Other team members such as thoracic radiology and pulmonary pathology may not directly interact with the patients, but their input is nonetheless crucial in formulating an appropriate diagnosis and treatment plan. Input from all the relevant specialists is taken into account when making diagnostic and therapeutic decisions for all patients.

This multidisciplinary approach is considered the standard of care and leads to better diagnostic and therapeutic decisions in patients with interstitial lung disease.

Interstitial Lung Diseases Program Faculty

Patients referred to the ILD clinic will generally see one of our pulmonary physicians specializing in interstitial lung disease, who will then involve other team members as needed.

Interstitial Lung Disease

Patients with interstitial lung disease and pulmonary fibrosis are often first seen and evaluated by our pulmonary physicians specializing primarily in interstitial lung diseases. These patients may then be referred to be seen by other specialist team members as needed.

Rishi Raj, MD

Clinical Professor of Medicine

Rish Raj MD is a Clinical Professor of Medicine at Stanford University and directs the Interstitial Lung Disease program at Stanford. Dr. Raj's clinical interest and focus of clinical research are idiopathic interstitial lung diseases and interstitial lung diseases related to other causes.  Dr. Raj is the principal investigator and co-investigator on multiple clinical trials evaluating new therapies for treating idiopathic pulmonary fibrosis and pulmonary fibrosis/interstitial lung disease from other etiologies.

 Less 

Joshua Mooney, MD, MS

Clinical Assistant Professor of Medicine

Joshua Mooney, MD, MS, is a board certified pulmonologist and critical care physician who specializes in the care of interstitial lung disease and lung transplant patients. He performs health services and outcomes research focused on understanding and improving the lives and care of patients with advanced lung disease and is actively involved in clinical trials to improve outcomes in interstitial lung disease. He is the director of the Pulmonary Fibrosis Foundation Care Center at Stanford and serves on national and international committees related to pulmonary fibrosis and lung transplantation.

Tushar Desai, MD, MPH

Associate Professor of Medicine

Tushar Desai MD, MPH specializes in the treatment of general pulmonary and Interstitial Lung Diseases like Idiopathic Pulmonary Fibrosis (IPF). He has practiced pulmonary medicine since 2002. Dr. Desai has a special interest in understanding the development and progression of diseases like IPF, Chronic Obstructive Pulmonary Disease (COPD), and lung adenocarcinoma, as well as in understanding how native lung stem cells function to repair the lung gas exchange surface after injury.

 

Shahzad Ahmad, MD

Clinical Assistant Professor of Medicine

Shahzad Ahmad, MD, FCCP, is a board certified pulmonary and critical care physician with extensive clinical experience in Interstitial Lung Diseases, Pulmonary Hypertension and Lung Transplantation. He has special interest and expertise in the diagnosis and management of patients with Idiopathic Pulmonary Fibrosis (IPF), Idiopathic Interstitial Pneumonias, Hypersensitivity Pneumonitis, Connective Tissue Disorders, Sarcoidosis, other ILD’s, Pulmonary Hypertension and complex pulmonary disorders.

Dr. Ahmad has been involved in clinical research in IPF, Pulmonary Hypertension, and Lung Transplantation for the past 18 years, and strives to bring novel therapies for these patients. He has co-authored over 30 peer-reviewed manuscripts and has presented over 100 abstracts at many national and international conferences.

Emily Casabar, RN, NP

 

 

Emily received her Bachelors of Science Degree in Nursing from California State University, Bakersfield.  She received her Master’s of Science Degree in Nursing, FNP, at Holy Names University in Oakland, CA.   She worked as a critical care registered nurse for 9 years prior to working as a pulmonary/critical care nurse practitioner.  In March 2017, she joined the Stanford Center for Advanced Lung Disease as a Nurse Practitioner.  In addition to providing patient education, she works in collaboration with other providers to diagnose and treat ILD patients.

Jonathan Cheong, PA-C

Jonathan received his Bachelor of Sciences in Physiological Sciences from the University of California, Los Angeles and his Master of Sciences in Physician Assistant studies at Western University of Health Sciences in Pomona, CA. He joined the Interstitial Lung Disease program at Stanford as a Physician Assistant in December 2019. His role on the team is to work alongside the other providers to diagnose and treat patients with interstitial lung disease. In his free time, Jonathan enjoys watching and playing basketball, drinking good coffee, and eating delicious food.

Christine received her Bachelor of Arts and Science from the University of Colorado, Boulder and her Bachelor of Science in Nursing from Samuel Merritt University.  Her nursing background is in Primary Care where she worked at a Community Health Center and served as Triage Nurse, Manager of Nursing Services, and Clinic Manager.  In April 2018, she joined the Interstitial Lung Disease Program at Stanford as a Nurse Coordinator.  She works in collaboration with our health care team to provide patient education and ensure continuity of care.

Teddy Simpson, RN

ILD Nurse Coordinator

Need link

Teddy Simpson received her Associate Degree in Nursing  at De Anza College, and her Bachelor of Science in Nursing from San Jose State University. Her background is in primary care, having worked at a community college, serving as Triage Nurse, Health Educator and providing Nursing Advice for students and staff. She has also worked with a Community Health Center and served as Triage Nurse and Clinic Manager. Teddy joined the ILD program at Stanford as a Nurse Coordinator in September 2018. She works closely with the ILD team to provide coordination of care for the patient and their providers, ensuring high quality patient care and continuity of care. Her interests are traveling, cooking and spending time with her family.

Mary Ann Boland BSN.  Mary Ann Boland graduated fromm Simmons College 1981 with a BSN.  She worked in a General Medical/Surgical unit at Marian Hospital in Providence RI, in a Telemetry Unit for Post-Operative Cardiac Surgery patients at Stanford Medical Center, in an Acute Rehabilitation Program with patients with spinal cord and head injuries, Guillain Barre, stroke  St Mary’s Hospital  and as a Hospice Nurse/case manager with Pathways Homecare and Hospice.  She is currently a Nurse Coordinator in Stanford’s Chest Clinic working with the Interstitial Lung Disease Program and Pulmonary Fellows team.

Gemma Diaz, RN

ILD Nurse Coordinator

CAP Profile

Gemma Diaz started as an RN in Las Vegas, Nevada, and later became a travel nurse in  Nevada and California working in Cardiology/Telemetry, Medical/Surgical and Orthopedics. She received her Bachelors Degree in Psychology from St. Louis University in the Philippines, Nursing degree from Johns Hopkins University Affiliate School in Howard County, Maryland, and dual Masters Degree in Business Administration and Healthcare Management from University of Phoenix in Arizona.  In 2014,  she began at Stanford Healthcare with the Case Management/Social Work Team where she covered multiple specialty and General Medicine Services.  Gemma joined the Interstitial Lung Disease Program at Stanford as a Nurse Coordinator in late 2019.  

Dulce Moreno

Patient Care Coordinator, Stanford ILD Clinic

Dulce M. Moreno has been part of the Stanford Chest Clinic for the past 10 years.  For the first four years she was at the Front Desk greeting and checking in patients for their appointments.  In 2012, she joined the Center for Advanced Lung Disease working with ILD and CF patients as the Advanced Lung Disease Coordinator.  She scheduled both new and return patients and all the testing that is required.  Dulce is the main point of contact for all new patients and referring physicians. She also requests all records for the RNs and MDs to review.  Dulce’s favorite things to do are reading, being with her family, and traveling.

Michael Sousa

Patient Care Coordinator, Stanford ILD Clinic

Michael Sousa has been a part of the Stanford Chest Clinic for the past 6 years.  He started as a Medical Assistant/Clinical Assistant for the first 5 years.  In November of 2019, he took a position as a Patient Care Coordinator with the Center of Advanced Lung Disease working to schedule new and returning patients.  Michael also obtains all of the outside records necessary to ensure the nurses and physicians have what they need to complete a meaningful visit with the patient.  Michael’s outside interests include being with his family, traveling, cycling, and playing soccer.

Amy Cabilatazan has been working at Stanford Health Care for 13 years. First, at the Cancer Center, and for the past year with the Interstitial Lung Disease Program as the New Patient Coordinator. Amy also coordinates and schedules appointments for the ILD outreach clinics in Fresno, Las Vegas and Monterey. She retrieves and assembles medical data that is then presented to the physicians and nurses, providing them with accurate information, facilitating the flow of communication and maximizing efficiency for patient evaluation and best patient quality care. Her interests are cooking, hiking, traveling and spending time with family and friends.

Joan Sugatan

Patient Care Coordinator, Stanford ILD Clinic

Joan G. Sugatan started working for Stanford as a Temp, floating to all sub-specialty departments of Chest Clinic. She assisted with all the referrals, scheduling appointments and requesting medical records for incoming patients. After working for almost 2 years, Stanford hired her as one of the Advanced Lung Disease Patient Care Coordinators. She helps scheduling both new and returns patients together with all the testing that is required and requesting medical records for review.  Joan loves to eat out with the whole family, and she enjoys reading books and watching movies as well.

Susan Jacobs RN, MS

Nurse Coordinator, Research Nurse Manager

Susan Jacobs received her undergraduate nursing degree from California State University, Chico, and her graduate degree in Pulmonary Nursing from University of California, San Francisco. Her background includes roles as a Critical Care Nurse Educator, NIH Project Director for a Dyspnea and Exercise protocol, and Coordinator of Pulmonary Rehabilitation.  Currently she is the Research Nurse Manager and Nurse Coordinator in the Division of Pulmonary and Critical Care Medicine, Stanford University Medical Center. More Susan has been with the Interstitial Lung Disease Program at Stanford since its inception in 2004. She coordinates the ILD Support Group and patient education in the ILD clinic, and supports the clinical research program in the Pulmonary Division. Her publications include results from a national patient survey describing oxygen problems experienced by patients and the official American Thoracic Society Workshop report "Optimizing Home Oxygen Therapy".

 Less 

Karen Morris, PhD

Clinical Research Coordinator

Karen Morris received her PhD from the University of California, Davis in Comparative Pathology for research on the molecular pathogenesis of infectious diseases. She previously earned a Doctor of Veterinary Medicine degree from the Federal University of Vicosa in Brazil. Karen has worked as a Research Scientist at biotech companies in the San Francisco Bay Area, where she developed assays for pharmacokinetic analysis of investigational drugs during pre-clinical studies. This experience initiated her interest in clinical research, and  More she later completed the Clinical Trials Design and Management program at the University of California, Santa Cruz. Karen joined the Interstitial Lung Disease Program in the Division of Pulmonary and Critical Care Medicine at Stanford in 2013, where she works as a Clinical Research Coordinator. She is responsible for the management and coordination of all aspects, including regulatory compliance, of a variety of large and small clinical research studies for prospective pulmonary investigational drugs and therapies

 Less 

Tal Alfasi received her undergraduate degree in Chemical Engineering and her Master’s degree in Health Sciences from Ben-Gurion University, Israel. Her background includes roles as an in-vitro Lab manager, a Clinical Research monitor and a clinical research QA/QC Project Manager.  Currently she is a Clinical Research Coordinator in the Division of Pulmonary and Critical Care Medicine, Stanford University Medical Center. Tal has been with the Interstitial Lung Disease Program at Stanford since 2010. She is part of the clinical research program in the Pulmonary Division, working on multiple studies related to ILD, lung transplant and infectious disease.

Rosemary Vojnik received her undergraduate degree in Molecular Biology from San Jose State University and brings more than twenty years of operational and finance management to the Division. She has been a Clinical Research Coordinator with the Division of Pulmonary & Critical Care Medicine at Stanford since 2011 and has managed clinical research trials with Interstitial Lung Disease and lung transplant programs. Her current focus is managing several NIH-sponsored studies in the Critical Care setting in patients with Acute Respiratory Distress Syndrome, sepsis and aspiration, while continuing to support clinical trials in the Advanced Lung Disease program.

Lung Transplantation

Gundeep Dhillon, MD

Associate Professor of Medicine

Dr. Dhillon  MD is a Clinical Professor of Medicine at Stanford University and directs the Heart-Lung and Lung Transplantation program at Stanford. Dr. Dhillon is the principal investigator and co-investigator on multiple research projects focused on improving outcomes in the post-lung transplant period.

 Less 

Laveena Chhatwani, MD

Clinical Assistant Professor of Medicine

Laveena Chhatwani M.D.  is a Clinical Assistant Professor in the School of Medicine at Stanford University.  Dr. Chhatwani specializes in the management of Lung and Heart-Lung transplant patients. She has a special interest in the management of advanced interstitial lung disease and lung failure and her research focuses on improving outcomes in lung transplantation. Dr. Chhatwani  attends our weekly Interstitial Lung Disease Multi-Disciplinary Discussion rounds in order to provide expert opinion on potential lung transplant candidates and how to best optimize their post-transplant outcomes.  By collaborating closely with our lung transplant colleagues, the ILD team is able to identify potential candidates early, as well as to manage those patients who experience an acute exacerbation and may need urgent consultation and a rapid transplant evaluation. 

Joshua Mooney, MD, MS

Clinical Assistant Professor of Medicine

Joshua Mooney, MD, MS, is a board certified pulmonologist and critical care physician who specializes in the care of interstitial lung disease and lung transplant patients. He performs health services and outcomes research focused on understanding and improving the lives and care of patients with advanced lung disease and is actively involved in clinical trials to improve outcomes in interstitial lung disease. He is the director of the Pulmonary Fibrosis Foundation Care Center at Stanford and serves on national and international committees related to pulmonary fibrosis and lung transplantation.

 

Shahzad Ahmad, MD

Clinical Assistant Professor of Medicine

Dr. Ahmad specializes in interstitial lung diseases, pulmonary hypertension and lung transplant.

Thoracic Radiology

Specialized chest imaging plays a very important role in reaching the correct diagnosis in patients with interstitial lung diseases. Our thoracic radiologists regularly attend the weekly multidisciplinary interstitial lung disease conferences, and provide invaluable input in reaching the final diagnosis and treatment plan for our ILD patients.

Ann N.C. Leung

Professor of Radiology

Ann Leung MD is Professor of Radiology and Division Chief of Thoracic Imaging at Stanford University Medical Center.  Her current research and clinical interests focus on the use of high-resolution computed tomography of the thorax to diagnose and evaluate thoracic diseases, including interstitial lung disease.  Her research includes exploring automated classification of usual interstitial pneumonias using regional volumetric texture analysis as well as the use of CT to detect, characterize, and manage lung nodules.  Dr. Leung provides expert radiologic consultation during our weekly Interstitial Lung Disease Multi-Disciplinary Discussion.

Henry Guo MD, PhD

Associate Professor of Radiology

Dr. Guo is a diagnostic radiologist with subspecialist expertise in chest radiology and nuclear medicine. Dr. Guo's clinical focus is on diseases of the lungs, including: interstitial lung disease, COPD, lung cancer, and diseases of the airways. Dr. Guo works closely with our pulmonary medicine colleagues and regularly contributes to the multi-disciplinary interstitial lung diseases conferences; helping the team reach the correct diagnosis based on each patient's radiologic findings.  His research program is active in quantitative lung CT, early detection of lung cancers, low radiation dose CT imaging, medical 3D printing, and combining the tools of molecular and anatomic imaging to help improve patients' outcomes.

Emily Tsai

Clinical Instructor of Radiology

Emily Tsai MD is a Clinical Instructor in the Department of Radiology at Stanford Universtiy Medical Center.  Her research areas include correlation of radiologic and pathologic findings, radiology-related quality improvement initiatives, and cost effectiveness analysis. She provides radiologic expertise during our weekly ILD Multi-Disciplinary Discussions.

Pulmonary Pathology

Patients with interstitial lung disease undergo a lung biopsy when a diagnosis cannot be made with less invasive means.  Pulmonary pathologists review and interpret the histopathologic findings, and participate in the multidisciplinary ILD conference to reach the correct diagnosis.

Gerald Berry

Professor of Pathology

Gerald Berry, M.D., is Professor of Pathology, Director of Anatomic Pathology and Director of Cardiac and Pulmonary Pathology.  His research interests include cardiopulmonary transplantation, inflammatory cardiac disorders, vasculitis and pulmonary hypertension.  Dr. Berry is the expert ILD pathologist who is a key participant in our weekly ILD Multi-Disciplinary Discussion patient rounds when clinical, pathologic, and radiologic results are reviewed to achieve consensus on patients’ diagnosis and treatment plan.

Rheumatology

Connective tissue diseases like Scleroderma or Rheumatoid Arthritis etc. are commonly associated with interstitial lung disease. In fact, one of the first things to do when an interstitial lung disease is first diagnosed, is to look for an underlying or coexistent connective tissue disease because this has important diagnostic, prognostic and therapeutic implications. It is common for patients with interstitial lung diseases to be referred for a formal rheumatology evaluation if the suspicion of underlying connective tissue disease is high. Similarly, it is not uncommon for patients with connective tissue diseases like Scleroderma or Rheumatoid Arthritis etc. to have an underlying interstitial lung disease. Pulmonologists and Rheumatologists work closely with each other to co-manage these patients with interstitial lung diseases and connective tissue diseases.

Lorinda Chung, MD

Associate Professor of Medicine

CAP Profile

Dr. Chung is an Associate Professor of Medicine (Immunology and Rheumatology) and Dermatology at Stanford University School of Medicine. Dr. Chung initiated and developed the Stanford Scleroderma Center of Excellence Dr. Chung co-attends the Rheumatologic Dermatology Clinic with Dr. David Fiorentino (Dermatology) where the majority of patients have systemic sclerosis, dermatomyositis, or related connective tissue diseases.

Yashaar Chaichian, MD

Clinical Assistant Professor

Yashaar Chaichian MD is a Clinical Assistant Professor within the Division of Immunology & Rheumatology and the Director of the Stanford Lupus Clinic. In addition, he has a strong clinical interest and expertise in the evaluation and management of patients with connective tissue disease-associated interstitial lung disease (CTD-ILD). He believes in a patient-centered and collaborative approach, and works closely with members of the Stanford Division of Pulmonary, Allergy & Critical Care to evaluate and manage patients with autoimmune lung disease."

Dermatology

Interstitial lung diseases such as those associated with connective tissue diseases like scleroderma and dermatomyositis can have prominent dermatologic findings and symptoms. Pulmonary physicians work with dermatologists to co mange these ILD patients with skin involvement due to these diseases.

David F. Fiorentino M.D. Ph.D. is a Professor in the Department of Dermatology and the Department of Immunology and Rheumatology at Stanford University School of Medicine. He is especially interested in patients with rheumatic skin disease, focusing on patients with myositis, systemic sclerosis and lupus.  He is interested in identifying serologic markers (autoantibodies) that identify ILD risk groups and in using these markers as well as skin rashes to identify patients at high risk for ILD.  Because the incidence of interstitial lung disease is especially high in these patients, he helps to provide expert consultation on patients with ILD in this clinic, both in assessing patients for a possible accompanying autoimmune diagnosis as well as providing input for optimal medical management of the patient.

Interventional Pulmonology

The interventional pulmonary team is an integral part of our diagnostic team for interstitial lung disease patients for whom minimally invasive sampling of the lungs are indicated. The interventional team works closely with the ILD program to optimize patients' diagnostic pathways to assist with management strategies.

Arthur Sung

Clinical Associate Professor of Medicine

Arthur Sung M.D. is a Clinical Associate Professor in the Department of Pulmonary and Critical Care at Stanford University School of Medicine, and the Director of the Interventional Pulmonology program. Dr. Sung is an expert at performing bronchoscopy, bronchoalveolar lavage, transbronchial forceps biopsy and transbronchial cryobiopsies for patients with interstitial lung diseases.

Harmeet Bedi, MD

Clinical Assistant Professor of Medicine

Dr. Harmeet Bedi is an Interventional Pulmonologist and Clinical Assistant Professor at Stanford University Medical Center and School of Medicine. His expertise is in minimally invasive  and innovative techniques used in the diagnosis of various interstitial lung diseases. Dr. Bedi has specific training in transbronchial cryobiopsy, rigid bronchoscopy, airway stent placement, balloon bronchoplasty, endobronchial ultrasound (EBUS) and electromagnetic navigation bronchoscopy, bronchial thermoplasty, intrabronchial valve (IBV) insertion, pleural catheter insertion, and medical thoracoscopy.

Meghan Ramsey, MD

Clinical Assistant Professor of Medicine

Dr. Meghan Ramsey is an interventional pulmonologist and Clinical Assistant Professor at Stanford, and performs minimally invasive procedures such as transbronchial forceps biopsy in patients with interstitial lung diseases.

Dr. Diana H. Yu is an Interventional Pulmonologist and Clinical Assistant Professor of Medicine at Stanford University School of Medicine. Her areas of clinical expertise include minimally invasive diagnostic and therapeutic bronchoscopic and pleural procedures. She has sub-specialty training in rigid bronchoscopy, radial/linear endobronchial ultrasound (EBUS), electromagnetic navigational bronchoscopy, indwelling pleural catheter placement, thoracostomy tube insertion, medical thoracoscopy, and whole lung lavage.

Thoracic Surgery

Interstitial lung disease patients may need a surgical lung biopsy if non-invasive or less invasive means do not allow a specific diagnosis despite multidisciplinary discussion. We routinely refer ILD patients to our thoracic surgery colleagues who specialize in minimally invasive video assisted thoracic surgery techniques for lung biopsy.

Joseph Shrager, MD

Professor of Cardiothoracic Surgery

CAP Profile

Dr. Joseph Shrager is a professor of cardiothoracic surgery and   Chief of the Division of Thoracic Surgery at the Stanford University Medical Center. Dr. Shrager provides surgical consultation for our ILD patients who need a surgical lung biopsy, and he specializes in minimally invasive techniques, including video-assisted thoracoscopic surgery (VATS) and robot-assisted operations. Dr. Shrager has been identified as one of “America’s Top Doctors” and one of “America’s Top Doctors for Cancer” in Castle Connolly’s prestigious listings for multiple years running.

Natalie Lui, MD

Assistant Professor of Cardiothoracic Surgery

Natalie Lui, MD, MAS is an Assistant Professor in the Division of Thoracic Surgery at Stanford. Dr. Lui’s clinical focus extends to all aspects of general thoracic surgical diseases, and her research focus is both clinical and translational. Dr. Lui provides surgical consultation for our ILD patients who need a surgical lung biopsy to confirm a specific ILD diagnosis. She specializes in minimally invasive techniques, including video-assisted thoracoscopic surgery (VATS) and robot-assisted operations.

Mark Berry, MD

Associate Professor of Cardiothoracic Surgery

Dr. Mark Berry is an Associate Professor in the Division of Thoracic Surgery at Stanford University. Dr. Berry provides surgical consultation for our ILD patients who need a surgical lung biopsy to confirm specific ILD diagnosis. He has a particular interest in minimally invasive techniques, serves as the co-Director of the Stanford Minimally Invasive Thoracic Surgery Center (SMITS), and has both directed and taught in several minimally invasive national and international thoracic surgery courses.  He has also performed several research studies on the safety of lung surgery for patients with impaired lung function, including those with ILD.

Leah Backhus, MD, MPH, FACS

Associate Professor of Cardiothoracic Surgery

Dr. Leah Backhus is an Associate Professor of cardiothoracic surgery at Stanford. Dr. Backhus provides surgical consultation for our ILD patients who need a surgical lung biopsy to confirm a specific ILD diagnosis. She specializes in minimally invasive techniques, including video-assisted tthoracoscopic surgery (VATS) and robot-assisted operations.

Palliative Care Medicine

Patients with interstitial lung diseases often have bothersome clinical symptoms such as cough and difficulty breathing which can be hard to treat. While we have made significant progress in treating interstitial lung diseases in the last decade, many interstitial lung diseases eventually progress despite the best available therapies. Palliative care physicians, who form an important part of our ILD team, help us treat symptoms associated with ILDs, and help empower patients to navigate this journey which can sometimes be difficult without adequate help and support.

Winifred Teuteberg, MD

Clinical Associate Professor of Medicine

Dr. Teuteberg completed residency training in Internal Medicine at the University of Chicago and a Palliative Medicine Fellowship at Massachusetts General Hospital. She is board-certified in Hospice and Palliative Medicine, Internal Medicine and Clinical Informatics. Dr. Teuteberg is currently leading the development of a cardiopulmonary palliative care program for patients with serious heart and lung disease in the ambulatory setting.